expected excessive body heigth
Conditions
Interventions
Trade Name: Bupivacaïne Actavis
Product Name: Bupivacaïne
Product Code: RVG 20951
Pharmaceutical Form: Solution for infusion in administration system
Trade Name: Morfine HCl CF
Product Name: Morfine
Sponsors
Maxima Medical center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: age 12-16 year; “indication for epiphysiodesis”, namely expected final height of boys of minimally 200 cm; for girls 195 cm. Are the trial subjects under 18? yes Number of subjects for this age range: 70 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: insufficient command of Dutch language; and not willing to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: What is the most effective postoperative pain treatment after a epiphysiodesis procedure?;Secondary Objective: pain two weeks postoperative; comedication use; adverse events; satsifaction rate of the patient;Primary end point(s): amount pain during first 5 days postoperative;Timepoint(s) of evaluation of this end point: first 5 days after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): pain after two and 6 weeks; comedication use; adverse events; satisfaction rate of the patient;Timepoint(s) of evaluation of this end point: 2 and 6 weeks and 6 months | — |
Countries
Netherlands
Contacts
Public ContactOrthopedics
Maxima Medical Center
Outcome results
None listed